Froimson Mark
Reporting owner on Forms 3, 4 and 5, CIK 1709050.
Froimson Mark reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-17.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| PCRX · Pacira BioSciences, Inc.CIK 1396814 | director | 1 | 2026-11-17 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| PCRX · Pacira BioSciences, Inc.Common Stock | 2026-11-17 | U | -20,136 | $36.5 | 6,405 | Form 4 |
| PCRX · Pacira BioSciences, Inc.Common Stock | 2026-11-17 | D returned to the issuer | -6,405 | $36.5 | 0 | Form 4 |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -4,693 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -8,437 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -8,027 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -7,626 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -8,225 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -12,925 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -11,279 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -10,891 | 0 | Form 4 | |
| PCRX · Pacira BioSciences, Inc.Stock Option (Right to Buy), derivative | 2026-11-17 | D returned to the issuer | -8,144 | 0 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001628280-26-074529 | Pacira BioSciences, Inc. | 2026-11-17 |